PACE IBD Telemedicine Research

The PACE IBD Telemedicine Program is currently welcoming participants into Promoting Access and Care at Centres of Excellence (PACE) telemedicine study.

What are we studying?
As an Inflammatory Bowel Disease (IBD) patient, you are an ideal candidate to determine whether there is a difference in the quality of IBD care received via a telemedicine network as compared to in person care received at a Centre of IBD Excellence. While we know that there is substantial geographical variation in the proportion of newly diagnosed IBD patients who receive gastroenterology care within the first year of diagnosis, it is not clear whether an IBD telemedicine will be effective in delivering high quality specialist IBD care to patients in underserved areas. Therefore, we are conducting this study to see whether an IBD telemedicine network is effective in delivering high quality IBD care to patients in underserved areas, by comparing telemedicine IBD care to in-person IBD care received at Mount Sinai Hospital.

Principal Investigator: Dr. Geoffrey Nguyen
Co-Investigators: Dr. Adam Weizman, Dr. Mark Silverberg, Dr. Kenneth Croitoru, Dr. Hillary Steinhart

Sponsor: Crohn’s and Colitis Canada

Who are we looking for?
All new patients over the age 18 years who are receiving telemedicine IBD care in underserved communities or in-person IBD care at Mount Sinai Hospital from a participating study gastroenterologist will be approached to participate in the study.

For further information regarding the PACE IBD telemedicine program, please contact:

Peter Habashi, RN, MN, BScN, HBSc - PACE Telemedicine Coordinator
Mount Sinai Hospital - Zane Cohen Centre for Digestive Diseases
Phone: 416-586-4800 x 2188 Fax: 416-586-5971
PaceIBD.MSH@SinaiHealth.ca